Track Electromed, Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Electromed, Inc. ELMD · Stock Open Electromed, Inc. in new tab

42.30 USD
Add to portfolio
P/E
33.44
EPS
1.17
P/B
6.59
ROE
21.70
Beta
0.52
Target Price
40.33 USD
Electromed, Inc. logo

Electromed, Inc.

🧾 Earnings Recap – Q3 2026

Electromed’s Q3 results surpassed expectations, driving a 31.2% stock rally, powered by broad-based revenue growth, significant margin expansion, and strong execution in both commercial and clinical initiatives.

  • Revenue grew 18.4% year-over-year to $18.6 million, supported by a 19% increase in Home Care and a 43% rebound in Hospital sales.
  • Operating income surged 76% to $3.8 million, reflecting meaningful margin improvement.
  • Diluted EPS rose 67% to $0.35, marking continued profitability gains.
  • The company advanced adoption with over 40% of orders through its Smart Order ePrescribe system, shortening shipment times by 5 days.
  • Clinical education efforts and the Triple Down on Bronchiectasis campaign are driving awareness in a large underpenetrated patient market.
📅
1M 6M YTD 1Y 2Y 5Y Max
Loading chart...
Key Metrics
Earnings dateAug. 25, 2026
P/E33.44
EPS1.17
Book Value5.94
Price to Book6.59
Debt/Equity0.17
% Insiders21.439%
Growth
Revenue Growth0.18%
Earnings Growth0.67%
Estimates
Forward P/E64.13
Forward EPS0.61
Target Mean Price40.33

DCF Valuation

Tweak assumptions to recompute fair value for Electromed, Inc. (ELMD)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result
Fair Value (DCF)
—
Current Price
—
Upside
—
WACC
—
Terminal PV
—
Σ PV of FCFs
—
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Electromed, Inc. Logo Electromed, Inc. Analysis (ELMD)

United States Health Care Official Website Stock

Is Electromed, Inc. a good investment? Electromed, Inc. (ELMD) is currently trading at 42.30 USD. Market analysts have a consensus price target of 40.33 USD. This suggests the asset is currently trading above analyst expectations.

In terms of valuation, the stock trades at a P/E ratio of 33.44. This high multiple suggests investors have priced in significant future growth expectations.

Earnings Schedule: Electromed, Inc. is expected to release its next earnings report on Aug. 25, 2026. The market consensus estimate for Forward EPS is 0.61.

Investor FAQ

Does Electromed, Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is Electromed, Inc.?

Electromed, Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be Aug. 25, 2026. The company currently has a trailing EPS of 1.17.

Company Profile

Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy, muscular dystrophies, amyotrophic lateral sclerosis, and post-surgical complications; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. It markets its products to physicians, health care providers, and directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.

Exchange Ticker
ASE (United States) ELMD
Trades
No dividend information available for this instrument.
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion